DRTS · Alpha Tau Medical
AI read · Good for DRTS
The AI's read
The findings give the treatment a promising early signal, and FDA approval lets researchers test it in more people. Completing enrollment in the pancreatic cancer study and $99.8 million in cash support continued research. The results come from small studies, so they do not yet show how well treatment works for a wider group.